Merck & Co Inc. MRK on Monday said its investigational therapy tulisokibart achieved the primary endpoint in a Phase 3 study ...

These positive Phase 3 induction results for tulisokibart are the first for an anti-TL1A biologic. They represent an important step forward for patients with moderately to severely active ulcerative ...

Ulcerative colitis can negatively affect how you feel about your body. Find out what experts recommend to help improve your ...

Merck on Monday said the Phase 3 induction-only study met its primary endpoint of clinical remission at week 12, as well as key secondary endpoints in patients with moderately to severely active ...

COLUMBUS, Ohio (WCMH) — Hundreds of families are expected to take part in Take Steps Central Ohio at Coffman Park in Dublin ...

ABIVAX Société Anonyme (NASDAQ:ABVX) is one of the best up and coming stocks to buy for the next 3 years. On June 1, Abivax ...

Our gut is the key to much of our body's overall health, which is why diseases like ulcerative colitis can be so detrimental. Ulcerative colitis is one of the most common inflammatory bowel diseases.

Immune checkpoint inhibitors are a form of cancer immunotherapy successfully used to treat a wide range of cancers. However, ...

Amebic Colitis is caused by the anaerobic parasitic amoebozoan Entameba histolytica. This bacterium infects the mucosa in the colon and accounts for 100,000 deaths annually. The parasite infects 10% ...

Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD). It causes painful sores and inflammation deep inside your colon and rectum. That can lead to hard-to-manage symptoms like ...

Hundreds of people gathered at the Grant Pavilion at Millennium Park in Walker on Saturday to show support for those ...